NewFocus Financial Group’s Gilead Sciences GILD Stock Holding History

NewFocus Financial Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,859	Closed	-$297K	–	114
2020 Q2	$297K	Hold	3,859	–	–	0.11%	94
2020 Q1	$288K	Sell	3,859 -1,300	-25%	-$89.8K	0.13%	78
2019 Q4	$335K	Hold	5,159	–	–	0.13%	83
2019 Q3	$327K	Hold	5,159	–	–	0.14%	77
2019 Q2	$349K	Hold	5,159	–	–	0.16%	69
2019 Q1	$335K	Hold	5,159	–	–	0.17%	66
2018 Q4	$323K	Hold	5,159	–	–	0.19%	65
2018 Q3	$398K	Sell	5,159 -41	-0.8%	-$3.1K	0.22%	54
2018 Q2	$368K	Sell	5,200 -1,352	-21%	-$95.5K	0.22%	57
2018 Q1	$494K	Buy	6,552 +43	+0.7%	+$3.42K	0.31%	49
2017 Q4	$466K	Buy	6,509 +1	+0%	+$76	0.28%	51
2017 Q3	$527K	Buy	6,508 +208	+3%	+$15.9K	0.34%	44
2017 Q2	$446K	Hold	6,300	–	–	0.25%	47
2017 Q1	$428K	Buy	+6,300	New	+$443K	0.26%	44

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

NewFocus Financial Group's GILD Position: Q3 2020 in Review

NewFocus Financial Group sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 3,859 shares — an estimated $297K sold.

NewFocus Financial Group first reported a position in GILD in Q1 2017 and held it in 14 quarters. The position peaked at $527K in Q3 2017. 1,537 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

NewFocus Financial Group reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
NewFocus Financial Group sold 3,859 Gilead Sciences shares in Q3 2020, an estimated $297K.
NewFocus Financial Group first reported a position in Gilead Sciences in Q1 2017 and held it in 14 quarters.
NewFocus Financial Group's Gilead Sciences position peaked at $527K in Q3 2017.
1,537 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on NewFocus Financial Group's 13F filing for Q3 2020, filed 26 Oct 2020.